These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28674565

  • 1. [Anorectal adenocarcinoma after Infliximab treatment for fistulizing Crohn's disease].
    Smaali J, Sekkach Y.
    Pan Afr Med J; 2017; 26():172. PubMed ID: 28674565
    [No Abstract] [Full Text] [Related]

  • 2. An unusual case of anorectal carcinoma in a patient with Crohn's disease.
    Narilli P, Lai Q, Meo D.
    J Crohns Colitis; 2010 Jun; 4(2):219-20. PubMed ID: 21122512
    [No Abstract] [Full Text] [Related]

  • 3. Adenocarcinoma arising from chronic perianal crohn's disease: a case report.
    Massit H, Edderai M, Saouab R, Seddik H, El Fenni J, Benkirane A.
    Pan Afr Med J; 2015 Jun; 22():140. PubMed ID: 26889321
    [Abstract] [Full Text] [Related]

  • 4. Adenocarcinoma associated with perianal fistulas in Crohn's disease.
    Ogawa H, Haneda S, Shibata C, Miura K, Nagao M, Ohnuma S, Kohyama A, Unno M.
    Anticancer Res; 2013 Feb; 33(2):685-9. PubMed ID: 23393368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
    Chiba M, Tsuji T, Nakane K, Obara Y, Komatsu M.
    Inflamm Bowel Dis; 2020 Jan 01; 26(1):e4. PubMed ID: 31697829
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppression may exert a hypoxia-mediated carcinogenetic effect in long-standing fistulizing Crohn's disease.
    Pellino G.
    Eur J Gastroenterol Hepatol; 2014 May 01; 26(5):575-6. PubMed ID: 24694737
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anal and rectal cancer in Crohn's disease.
    Sjödahl RI, Myrelid P, Söderholm JD.
    Colorectal Dis; 2003 Sep 01; 5(5):490-5. PubMed ID: 12925087
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
    Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P, Van Assche G.
    Clin Gastroenterol Hepatol; 2011 Feb 01; 9(2):130-6. PubMed ID: 21056696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is Hartmann's procedure safe in Crohn's disease? Report of three cases.
    Cirincione E, Gorfine SR, Bauer JJ.
    Dis Colon Rectum; 2000 Apr 01; 43(4):544-7. PubMed ID: 10789755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.